Open AccessIGHV mutational status and the choice of first-line therapy for patients with chronic lymphocytic leukaemia
Author(s) -
Bartosz Puła,
Krzysztof Jamroziak,
Tomasz Wróbel,
Krzysztof Giannopoulos,
Iwona Hus
Publication year - 2022
Language(s) - English
Resource type - Journals
ISSN - 2720-1015
DOI - 10.5603/hcp.2022.0003
Subject(s) - ighv@ , somatic hypermutation , chronic lymphocytic leukemia , oncology , medicine , malignancy , immunology , antibody , b cell , leukemia